21 completed, 1 recruiting, 1 terminated, 1 unknown. 8 Not applicable, 4 Phase 4, 3 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 7, Recruiting 1 |
| Phase 4 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Chlamydia Trachomatis: new trials by email Literature Review of Chlamydia Trachomatis trials Research Report on Chlamydia Trachomatis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Healthy Expectancy Through Routine Antenatal STI Screening Chlamydia trachomatis and Neisseria gonorrhoeae screening - Antenatal Health, Antenatal Care | Not applicable | Recruiting | Adriane Wynn | 2000 | 2026-05-25 | 2026-07-02 |
| Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany Chlamydia Trachomatis | Completed | Sanofi | 81239 | 2025-03-13 | 2026-05-04 | |
| Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) NAAT(s) - Chlamydia Trachomatis, Neisseria Gonorrhoeae | Not applicable | Completed | University Hospital, Strasbourg, France | 140 | 2024-04-05 | 2026-08-19 |
| Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile) First antenatal care + test-of-cure, First antenatal care + week 30-34 gestation (no test-of-cure) - Sexually Transmitted Infection, HIV/AIDS | Not applicable | Completed | Foundation for Professional Development (Pty) Ltd | 2247 | 2021-03-29 | 2026-07-17 |
| Self Sampling for Rapid Turnaround Testing in the Emergency Department vaginal self sampling, provider-performed endocervical sampling - Chlamydia Trachomatis, Neisseria Gonorrhoeae | Not applicable | Completed | University of California, San Francisco | 533 | 2018-09-17 | 2021-08-05 |
| Evaluation of the Atlas Genetics io® CTNG System Atlas Genetics io® system - Chlamydia Trachomatis, Gonorrhea | Completed | Binx Health Limited | 7128 | 2017-05-18 | 2020-04-03 | |
| Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years CTH522-CAF01, CTH522-Al(OH)3, Placebo - Chlamydia Trachomatis | Phase 1 | Completed | Statens Serum Institut | 35 | 2016-07-01 | 2017-08-10 |
| Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples Chlamydia Trachomatis, Gonorrhea | Terminated | Hologic, Inc. | 1766 | 2016-06-30 | 2017-03-24 | |
| Multimedia WORTH With Black Drug-Involved Women on Probation E-WORTH, Streamlined HIV Testing - Sexually Transmitted Infections, HIV | Not applicable | Completed | Columbia University | 354 | 2015-11-15 | 2020-07-27 |
| A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour Game-Based Appointment System - Sexually Transmitted Diseases, Chlamydia Trachomatis | Not applicable | Completed | University Hospital of North Norway | 996 | 2015-01-01 | 2016-01-05 |
| Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System APTIMA COMBO 2 Assay (AC2 Assay) - Chlamydia Trachomatis, Neisseria Gonorrhoeae Infection | Completed | Gen-Probe, Incorporated | 1912 | 2010-11-01 | 2014-01-14 | |
| Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System APTIMA Assay for Chlamydia trachomatis - Chlamydia Trachomatis | Withdrawn | Gen-Probe, Incorporated | 2010-11-01 | 2013-03-12 | ||
| Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Azithromycin, Doxycycline, lymecycline - Urethritis, Cervicitis | Phase 4 | Unknown | Ostergotland County Council, Sweden | 160 | 2010-02-01 | 2014-12-15 |
| Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing Trichomonas Vaginitis, Chlamydia Trachomatis | Completed | University of Pittsburgh | 305 | 2009-11-01 | 2016-05-18 | |
| Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients HIV Infections, Neisseria Gonorrhoeae | Completed | Insel Gruppe AG, University Hospital Bern | 300 | 2009-05-01 | 2011-01-13 | |
| Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger Azithromcyin, Azithromycin - Trachoma, Chlamydia Trachomatis | Phase 4 | Completed | University of California, San Francisco | 1139 | 2008-01-01 | 2012-05-08 |
| Washington State Community Expedited Partner Treatment (EPT) Trial Patient delivered partner therapy, Targeted public health partner services - Gonorrhea, Neisseria Gonorrhoeae | Phase 4 | Completed | University of Washington | 33222 | 2007-07-01 | 2012-08-17 |
| Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and Women. Home sampling (urine test) for uro-genital C.trachomatis. - Chlamydia Trachomatis, Mass Screening | Not applicable | Completed | Norwegian Institute of Public Health | 41719 | 2006-02-01 | 2010-03-03 |
| Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand Carraguard (PC-515) - HIV Infections, Chlamydia Trachomatis | Phase 1 | Completed | Population Council | 110 | 2001-06-01 | 2017-08-14 |
| Optimizing Strategies to Improve STD Partner Services Social Cognitive Counseling - Chlamydia Trachomatis, Neisseria Gonorrhoeae | Phase 1 | Completed | Centers for Disease Control and Prevention | 800 | 2001-06-01 | 2025-04-15 |
Showing 20 of 25. Sign in to see all of them.
Gonorrhea (9) · Sexually Transmitted Diseases (8) · Chlamydia Infections (4) · HIV Infections (4) · Trichomonas Vaginitis (4) · Syphilis (3) · Acquired Immunodeficiency Syndrome (2) · Herpes Simplex (2) · Trichomonas Infections (2) · Drug Misuse (1) · Infertility (1) · Pregnancy, Ectopic (1) · Premature Birth (1) · Trachoma (1) · Urethritis (1)
Genital Diseases (18) · Urogenital Diseases (18) · Infections (17) · Communicable Diseases (16) · Bacterial Infections (14) · Bacterial Infections and Mycoses (14) · Gram-Negative Bacterial Infections (14) · Sexually Transmitted Diseases, Bacterial (13) · Neisseriaceae Infections (9) · Disease Attributes (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Sexually Transmitted Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (7) · Blood-Borne Infections (5)
Azithromycin (3) · Ciprofloxacin (1) · Doxycycline (1) · Lymecycline (1) · Mass Screening (1) · Urinalysis (1)
Population Council (3) · Gen-Probe, Incorporated (2) · University of California, San Francisco (2) · University of Pittsburgh (2) · Adriane Wynn (1) · Binx Health Limited (1) · CHU de Quebec-Universite Laval (1) · Centers for Disease Control and Prevention (1) · Columbia University (1) · Foundation for Professional Development (Pty) Ltd (1) · Hologic, Inc. (1) · Insel Gruppe AG, University Hospital Bern (1) · Norwegian Institute of Public Health (1) · Ostergotland County Council, Sweden (1) · Sanofi (1)
United States (11) · Norway (2) · South Africa (2) · Thailand (2) · Benin (1) · Botswana (1) · Denmark (1) · France (1) · Germany (1) · Niger (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Jennifer Reid, PhD (2) · Abdou Amza, MD (1) · Andrew Medina-Marino, PhD, MPH (1) · Barbara Van der Pol, PhD (1) · Berit Andersen, MD, Ph.D. (1) · Brian Chinnock, MD (1) · Charlotte E. Ellertson, MPA, Ph.D. (1) · Elia Gabarron, MsC, Psych (1) · Elwin Wu, Ph.D. (1) · Hansjakob Furrer, MD (1) · Harold C Wiesenfeld, MD, CM (1) · Jeffrey Klausner, MD, MPH (1) · Julius Schachter, PhD (1) · Kelly Blanchard, MSc (1)
PMID 11807700, PMID 17301105, PMID 21097811, PMID 22421690, PMID 23343391, PMID 23920840, PMID 25590331, PMID 25890283, PMID 26283670, PMID 30201039, PMID 31416692, PMID 33835175, PMID 35610666, PMID 38396019, PMID 39039560, PMID 42078373, PMID 42715544
R01AI045468 (1), R01AI048789 (1), R01AI068107 (1), R01AI149339 (1), R01DA038122 (1), R01HD116989 (1)